滄州明珠(002108.SZ):擬投資4.45億元建年產38000噸高阻隔尼龍薄膜項目
格隆匯6月29日丨滄州明珠(002108.SZ)公佈,公司擬在河北省滄州市投資建設“年產38000噸高阻隔尼龍薄膜項目”。項目投資總金額4.45億元人民幣,主要投資建設高阻隔尼龍薄膜(BOPA薄膜)生產線2條,用於BOPA薄膜產品的生產。該項目資金公司通過自有資金及自籌資金等方式解決。
公司目前BOPA薄膜產品年設計產能28500噸,該項目年設計產能38000噸。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.